Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection

BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) pandemic has caused a significant impact on all aspects of life. One of the comorbidities associated with severe outcome and mortality of COVID-19 is diabetes. Metformin is one of the drugs which is most commonly used for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariyanto, Timotius Ivan, Kurniawan, Andree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434427/
https://www.ncbi.nlm.nih.gov/pubmed/32844132
http://dx.doi.org/10.1016/j.obmed.2020.100290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434427/
https://www.ncbi.nlm.nih.gov/pubmed/32844132
http://dx.doi.org/10.1016/j.obmed.2020.100290

Ejemplares similares